We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The Eversense® CGM is compatible with Glooko.
Syncing data to Glooko is initiated via the user’s Glooko account. They will need to know their Eversense username and password to link their Eversense account via Glooko.
There may be times when you wish to temporarily stop sharing data with a member, but not remove them from your Circle.
IMPORTANT: If you have disabled the Share My Data feature for a member, that member will not see any of your Eversense® CGM System glucose data, alerts or event history. Members will see your status as Offline on their Eversense® NOW App when you have disabled the Share my Data feature. It can take up to 10 minutes for the change to display on the Eversense® NOW user’s app.
An internet connection is required to download the app and to receive remote glucose values for display on your Eversense® NOW App.
Removing an Eversense® CGM user from your list means you will no longer be able to remotely monitor their glucose data. To add a user back to your list, contact the Eversense® CGM user to send you a new invitation.
To add a user back to your list, contact the Eversense® CGM user to send you a new invitation.
Note: It can take up to 2 hours for the Eversense® CGM user to see that you are no longer in their Circle on their Eversense® CGM App.
Yes.
(Customer Service team – see approved talking points/script on account deletion)
X-ray, CT Scan:
DO NOT wear the smart transmitter during medical x-rays or computed tomography (CT) scans. To avoid interference with results, remove the smart transmitter before undergoing medical x-ray or CT scans. Make sure your health care professional knows about your smart transmitter.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060